First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges

DOI Web Site 1 Citations

Alessandro Rizzo

Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy
Angela Dalia Ricci

Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy
Gennaro Gadaleta-Caldarola

Department of Medical Oncology, Medical Oncology Unit, “Mons. R. Dimiccoli” Hospital, Barletta (BT), ASL BT, Italy
Giovanni Brandi

Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy

Journal

Expert Review of Gastroenterology & Hepatology

Expert Review of Gastroenterology & Hepatology 15 (11), 1245-1251, 2021-08-31

Informa UK Limited

Back to top